Residence time of low-density lipoprotein in the normal and atherosclerotic rabbit aorta

Circulation Research

Volumn 80, Issue 2, 1997, Pages 208-218

  Tozer, Eileen Collins ^a,b   Carew, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

atherosclerosis; low density lipoprotein; residence time

Indexed keywords

IODINE 125; IODINE 131; LOW DENSITY LIPOPROTEIN;

ABDOMINAL AORTA; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERPLASIA; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RABBIT; THORACIC AORTA;

EID: 0031037026     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.2.208     Document Type: Article

References (77)

1. Strong JP, McGill HC. The natural history of coronary atherosclerosis. Am J Pathtol. 1961;40:37-49.
2. Stary HL. Evolution and progression of atherosclerosis in the coronary arteries of children and adults. In: Bates SR, Giangloff EC, eds. Atherogenesis and Aging. New York, NY: Springer-Verlag; 1987.
3. Small DM, Progression and regression of atherosclerotic lesions: insights from lipid physical biochemistry. Arteriosclerosis. 1988;8:103-129.
4. Poole JCF, Florey HW. Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits. J Pathol Bacteriol. 1958;75:245-251.
5. Stary HC, Malinow MR. Ultrastructure of experimental coronary artery atherosclerosis in cynomolgus macaques: a comparison with lesions of other primates. Atherosclerosis. 1982;43:151-175.
6. Newman HA, Zilversmit DB. Quantitative aspects of cholesterol flux in rabbit atheromatous lesions. J Biol Chem. 1962;237:2078-2084.
7. Christensen S. Transfer with labeled cholesterol across the aortic intimal surface of normal and cholesterol-fed cockerels. J Atheroscler Res. 1964;4:151-160.
8. Zilversmit DB. Cholesterol flux in the atherosclerotic plaque. Ann N Y Acad Sci. 1968;149:710-724.
9. Lipid Research Clinics Program. The Lipid Research Clinics coronary primary prevention trial results. II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;257:3233-3240.
10. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions: a review of autopsy studies. Arteriosclerosis. 1983;3:187-198.
11. Tyroler HA. Lowering plasma cholesterol levels decreases risk of coronary heart disease: an overview of clinical trials. In: Steinberg D, Olefsky JM, eds. Hypercholesterolemia and Atherosclerosis. New York, NY: Churchill Livingstone; 1987:99-116.
12. Goldstein JL, Brown MS, The low density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897-930.
13. Steinberg D. Lipoproteins and atherosclerosis: a look back and a look ahead. Arteriosclerosis. 1983;3:283-301.
14. Hoff HF, Bond MG. Accumulation of lipoproteins containing apo B in the aorta of cholesterol-fed cynomolgus monkeys. Atherosclerosis. 1982;43:329-339.
15. Hollander W, Paddock J, Colombo M. Lipoproteins in human atherosclerotic vessels, I: biochemical properties of arterial low density lipoproteins, very low density lipoproteins, and high density lipoproteins. Exp Mol Pathol. 1979;30:144-171.
16. Smith EB. Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina. Eur Heart J. 1990;11:72-81.
17. Ghosh S, Armstrong ML, Megan MB, Cheng FH. Arterial uptake indices of low density lipoproteins after fatty streak formation in Cynomolgus monkeys. Cardiovasc Res. 1987;21:14-20.
18. Schwenke DC, St Clair RW. Infflux, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of Whilte Carneau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis. Arterioscler Thromb. 1993;13:1368-1381.
19. Ghosh S, Finkelstein JN, Moss DB, Schweppe JS. Evaluation of the permeability parameters (influx, efflux and volume of distribution) of arterial wall for LDL and other proteins. Adv Exp Med Biol. 1975; 67:191-204.
20. Alavi M, Moore S. Kinetics of low density lipoprotein interactions with rabbit aortic wall following balloon catheter deendothelialization. Arteriosclerosis. 1984;4:395-402.
21. Wootton R, Baskerville P, Turner P, Insell M, Shaikh M, LaVille A, Quiney J, Browse NL, Lewis B. A method for quantifying lipoprotein flux rates between plasma and arterial intima in vivo. Clin Phys Physiol Meas. 1987;8:65-74.
22. Nordestgaard BG, Wootton R, Lewis B. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo: molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol. 1995;15:534-542.
23. Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol-fed rabbits, II: selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis. 1989;9:908-918.
24. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
25. Parthasarathy S, Steinberg D, Witztum JL, The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med. 1992;43:219-225.
26. Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol fed rabbits, I: focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis. 1989;9:895-907.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
28. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide. 1,3,4,6-tetrachloro-3α,6α-diphenylglycoluril. Biochem Biophys Res Commun. 1978;80:849-857.
29. Schwenke DC, Carew TE, Quantification in vivo of increased LDL content and rate of LDL degradation in normal rabbit aorta occurring at sites susceptible to early atherosclerotic lesions. Circ Res. 1988;62:699-710.
30. Holman RL, McGill HC, Strong JP, Geer JC. The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the 20th century. Am J Pathol. 1957;226:497-509.
31. Carew TE, Pittman RC, Marchand ER, Steinberg D. Measurement in vivo of irreversible degradation of low density lipoprotein in the rabbit aorta: predominance of intimal degradation. Arteriosclerosis. 1984;4:214-224.
32. Wiklund O, Carew TE, Steinberg D. Role of the low density lipoprotein receptor in penetration of low density lipoprotein into rabbit aortic wall. Arteriosclerosis. 1985;5:135-141.
33. Slender S, Zilversmit DB. Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits: molecular size as a determinant of plasma lipoprotein influx. Arteriosclerosis. 1981;1:38-49.
34. Nielsen LB, Nordestgaard BG, Stender S, Kjeldsen K. Aortic permeability to LDL as a predictor of aortic cholesterol accumulation in cholesterol-fed rabbits. Arterioscler Thromb. 1992;12:1402-1409.
35. Bell FP, Gallus AS, Schwartz CJ. Focal and regional patterns of uptake and the transmural distribution of 1311-fibrinogen in the pig aorta in vivo. Exp Mol Pathol. 1974;20:281-292.
36. Shipley RA, Clark RE. Tracer Methods for In Vivo Kinetics, Theory and Applications. New York, NY: Academic Press Inc: 1972.
37. Olsson DM. A sequential simplex program for solving minimization problems. J Qual Technol. 1974;6:53-57.
38. Brown MS, Goldstein JL. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc Natl Acad Sci U S A. 1979;76:3330-3337.
39. Duncan LE, Cornfield J, Buck K. Circulation of iodinated albumin through aortic and other connective tissues of the rabbit. Circ Res. 1958;6:244-255.
40. Finkelstein JN, Ghosh S, Schwappe JS. Kinetic analysts of in vivo lipoprotein flux in the normal rabbit aorta. Artery. 1976;2:161-172.
41. Nordestgaard BG, Lewis B. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain. Atherosclerosis. 1991;87:39-46.
42. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: lipid and nonlipid factors. Circulation. 1990;81:470-476.
43. Tatami R, Mabuchi H, Ueda K, Ueda R, Hara T, Kametani T, Ito S, Koizumi J, Ohta M, Miyamoto S, Nakayama A, Kanaya H, Oiwake H, Genda A, Takeda R. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation. 1981;64:1174-1184.
44. Nagelkerke JF, Havekes L, van Hinsbergh VWM, van Berkel TJC. In vivo catabolism of biologically modified LDL. Arteriosclerosis. 1984;4:256-264.
45. Khouw AS, Parthasarathy S, Witztum JL. Radioiodination of low density lipoprotein initiates lipid peroxidation: protection by use of antioxidants. J Lipid Res. 1993;34:1483-1496.
46. Wunder A, Stehle G, Sinn H, Schrenk HH, Neufeld B, Dempfle CE, Dresel HA, Harenberg FE, Maier-Borst W, Heene DL. The injection of heparin prolongs the plasma clearance of oxidized low density lipoprotein in the rat. Thromb Res. 1995;78:139-149.
47. Deigner HP, Friedrich E, Sinn H, Dresel HA. Scavenging of lipid peroxidation products from oxidizing LDL by albumin alters the plasma half-life of a fraction of oxidized LDL particles. Free Radic Res Commun. 1992;16:239-246.
48. Portman OW, Illingworth DR, Alexander M. The effects of hyperlipidemia on lipoprotein metabolism in squirrel monkeys and rabbits. Biochim Biophys Acta. 1975;398:55-71.
49. Moerlein SM, Daugherty A, Sobel BE, Welch MJ. Metabolic imaging with gallium-68 and indium-111-labeled low density lipoprotein. J Nucl Med. 1991;32:300-307.
50. Hay RV, Fleming RM, Ryan JW, Williams KA, Stark VJ, Lathrop KA, Harper PV. Nuclear imaging analysis of human low density lipoprotein biodistribution in rabbits and monkeys. J Nucl Med. 1991; 32:1239-1245.
51. Berman M, Weiss MF. SAAM Manual. Washington, DC: US Government Printing Office; 1978. US Dept of Health, Education, and Welfare Publication NIH 78-180.
52. Stemerman MB, Morrel EM, Burke KR, Cotton CK, Smith KA, Lees RS. Local variation in arterial wall permeability to low density lipoprotein in normal rabbit aorta. Arteriosclerosis. 1986;6:64-69.
53. Schwenke DC, Carew TE. Determination of LDL degradation rate, content, and residence time in lesioned and nonlesioned aorta. Circulation. 1987;76(suppl IV):IV-313. Abstract.
54. Nievelstein PFEM, Fogelman AM, Mottino G, Frank JS. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein: a deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler Thromb. 1991;11:1795-1805.
55. Simionescu N, Vasile E, Lupu F, Popescu G, Simionescu M. Prelesional events in atherogenesis: accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol. 1986;123:109-125.
56. Sparrow CP, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoproteins. J Biol Chem. 1989;264:2599-2604.
57. Lougheed M, Zhang HF, Steinbrecher UP. Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. J Biol Chem. 1991;266:14519-14525.
58. Curran RC, Crane WA. Mucopolysaccharides in the atheromatous aorta. J Pathol Bacteriol. 1962;84:405-412.
59. Srinivasan SR, Dolan P, Radhakrishnamurthy B, Pargaonkar PS, Berenson GS. Lipoprotein-acid mucopolysaccharide complex of human atherosclerotic lesions. Biochim Biophys Acta. 1975;388:58-70.
60. Iverius PH. The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. J Biol Chem. 1972;247:2607-2613.
61. Nordestgaard BG, Tybjaerg-Hansen A, Lewis B. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits: roles of plasma concentration, extent of aortic lesion, and lipoprotein particle size as determinants. Arterioscler Thromb. 1992;12:6-18.
62. Nordestgaard BG, Zilversmit DB. Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits. J Lipid Res. 1988;29:1491-1500.
63. Frank JS, Fogelman AM. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J Lipid Res. 1989;30:967-978.
64. Walton KW, Williamson N. Histological and immunofluorescent studies on the evolution of the human atheromatous plaque. J Atheroscler Res. 1968;8:599.
65. Hoff HT, Jackson RL, Mao SJ, Gotto AM. Localization of low density lipoproteins in atherosclerotic lesions from human normolipemics employing a purified fluorescent labeled antibody. Biochim Biophys Acta. 1974;351:407.
66. Hollander W. Unified concept on the role of acid mucopolysaccharides and connective tissue proteins in the accumulation of lipids, lipoproteins and calcium on the atheroslcerotic plaque. Exp Mol Pathol. 1976;25:106-120.
67. Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Berenson GS. Collagenase-solubilized lipoprotein-glycosaminoglycan complexes of human aortic fibrous plaque lesions. Atherosclerosis. 1979;34:105-118.
68. Camejo G, Lopez A, Lopex F, Quinones J. Interaction of low density lipoproteins with arterial proteoglycans: the role of charge and sialic acid content. Atherosclerosis. 1985;55:93-105.
69. Hoff H, Wagner W. Plasma low density lipoprotein accumulation in aortas of hypercholesterolemic swine correlates with modifications in aortic glycosaminoglycan composition. Atherosclerosis. 1986;61:231-236.
70. Alavi M, Moore S. Glycosaminoglycan composition and biosynthesis in the endothelium-covered neointima of de-endothelialized rabbit aorta. Exp Mol Pathol. 1985;42:389-400.
71. Yla-Herrtuala S, Sumuvuori H, Karkola K, Mottonen M, Nikkari T. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest. 1986;54:402-407.
72. Hollman J, Schmidt A, Barthold van Bassewitz D, Buddecke E. Relationship of sulfated glycosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta. Arteriosclerosis. 1989;9:154-158.
73. Yla-Herttuala S, Solakivi T, Hervonen J, Laaksonen H, Mottonen M, Pesonen E, Raekallio J, Akerblom H, Nikkari T. Glycosaminoglycans and apolipoproteins B and A1 in human aortas: chemical and immunological analysis of lesion-free aortas from children and adults. Arteriosclerosis. 1987;7:333-340.
74. Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 1988;8:348-358.
75. Suits AG, Heinecke JW, Chait A. Novel mechanism for macrophage uptake of low density lipoprotein after self aggregation. Proc Natl Acad Sci U S A. 1989;86:2713-2717.
76. Hurt E, Bonjers G, Carnejo G. Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. J Lipid Res. 1990;31:443-454.
77. Hurt-Camejo, E, Camejo G, Rosengren B, Lopez F, Ahlstrom C, Fager G, Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb. 1992;12:569-583.